Small molecule procaspase activating compound 1 (PAC-1) enhances CAR-T immunotherapy for solid tumors in syngeneic murine models

被引：0
|
作者：
Ranoa, Diana R.
Kang, Yifei
Drnevich, Jenny
Rendon, Gloria
Fields, Christopher J.
Bailey, Keith
Roy, Edward J.
Fan, Timothy M.
Kranz, David M.
Hergenrother, Paul J.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-LB075
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB075
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Derivatives of Procaspase-Activating Compound 1 (PAC-1) and their Anticancer Activities
    Roth, Howard S.
    Hergenrother, Paul J.
    CURRENT MEDICINAL CHEMISTRY, 2016, 23 (03) : 201 - 241
  • [2] Phase I study of procaspase activating compound-1 (PAC-1) for treatment of advanced malignancies
    Danciu, Oana C.
    Holdhoff, Matthias
    Peterson, Richard A.
    Hergenrother, Paul J.
    Tarasow, Theodore M.
    Dudek, Arkadiusz Z.
    CANCER RESEARCH, 2020, 80 (16)
  • [3] Parallel Synthesis and Biological Evaluation of 837 Analogues of Procaspase-Activating Compound 1 (PAC-1)
    Hsu, Danny C.
    Roth, Howard S.
    West, Diana C.
    Botham, Rachel C.
    Novotny, Chris J.
    Schmid, Steven C.
    Hergenrother, Paul J.
    ACS COMBINATORIAL SCIENCE, 2012, 14 (01) : 44 - 50
  • [4] Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies
    Danciu, Oana C. C.
    Holdhoff, Matthias
    Peterson, Richard A. A.
    Fischer, James H. H.
    Liu, Li C. C.
    Wang, Heng
    Venepalli, Neeta K. K.
    Chowdhery, Rozina
    Nicholas, M. Kelly
    Russell, Meredith J. J.
    Fan, Timothy M. M.
    Hergenrother, Paul J. J.
    Tarasow, Theodore M. M.
    Dudek, Arkadiusz Z. Z.
    BRITISH JOURNAL OF CANCER, 2023, 128 (05) : 783 - 792
  • [5] Phase I study of procaspase activating compound-1 (PAC-1) for treatment of advanced malignancies.
    Danciu, Oana C.
    Nicholas, Martin Kelly
    Holdhoff, Matthias
    Peterson, Richard A.
    Tarasow, Theodore M.
    Hergenrother, Paul J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies
    Oana C. Danciu
    Matthias Holdhoff
    Richard A. Peterson
    James H. Fischer
    Li C. Liu
    Heng Wang
    Neeta K. Venepalli
    Rozina Chowdhery
    M. Kelly Nicholas
    Meredith J. Russell
    Timothy M. Fan
    Paul J. Hergenrother
    Theodore M. Tarasow
    Arkadiusz Z. Dudek
    British Journal of Cancer, 2023, 128 : 783 - 792
  • [7] Phase I study of procaspase activating compound-1 (PAC-1) in the treatment of advanced malignancies.
    Danciu, Oana Cristina
    Nicholas, Martin Kelly
    Holdhoff, Matthias
    Venepalli, Neeta K.
    Hergenrother, Paul J.
    Tarasow, Theodore M.
    Dudek, Arkadiusz Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Phase I study of procaspase activating compound-1 (PAC-1) in the treatment of advanced malignancies.
    Danciu, Oana C.
    Nicholas, Martin Kelly
    Emmadi, Rajyasree
    Xie, Hui
    Hergenrother, Paul J.
    Tarasow, Theodore M.
    Dudek, Arkadiusz Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Removal of Metabolic Liabilities Enables Development of Derivatives of Procaspase-Activating Compound 1 (PAC-1) with Improved Pharmacokinetics
    Roth, Howard S.
    Botham, Rachel C.
    Schmid, Steven C.
    Fan, Timothy M.
    Dirikolu, Levent
    Hergenrother, Paul J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (09) : 4046 - 4065
  • [10] New Procaspase Activating Compound (PAC-1) Like Molecules as Potent Antitumoral Agents Against Lung Cancer
    Yurttas, Leyla
    Ozturk, Omer
    Canturk, Zerrin
    LETTERS IN DRUG DESIGN & DISCOVERY, 2019, 16 (06) : 645 - 655
12345